GlaxoSmithKline (GSK) Q3 EPS Falls to 22.6p; Revs Lower Y/Y
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of 22.6 pence, versus 27.2 pence reported last year. Revenue for the quarter came in at GBP6.53 billion, versus GBP7.1 billion reported last year.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Park National Corp. (PRK) Tops Q1 EPS by 36c
- American International Group (AIG) PT Raised to $89 at Piper Sandler
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!